Fuliang Chu

Assistant Professor

  • 1398 Citations
  • 13 h-Index
20042019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Fuliang Chu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Follicular Lymphoma Medicine & Life Sciences
Severe Acute Respiratory Syndrome Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Crystallization Medicine & Life Sciences
T-cells Chemical Compounds
Coronavirus Medicine & Life Sciences
Regulatory T-Lymphocytes Medicine & Life Sciences
Tumor Microenvironment Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 1398 Citations
  • 13 h-Index
  • 26 Article
  • 2 Review article
1 Citation (Scopus)

CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity

Chu, F., Li, H. S., Liu, X., Cao, J., Ma, W., Ma, Y., Weng, J., Zhu, Z., Cheng, X., Wang, Z., Liu, J., Jiang, Z. Y., Luong, A. U., Peng, W., Wang, J., Balakrishnan, K., Yee, C., Dong, C., Davis, R. E., Watowich, S. S. & 1 others, Neelapu, S. S., Nov 1 2019, In : Leukemia. 33, 11, p. 2640-2653 14 p.

Research output: Contribution to journalArticle

T-Lymphocytes
Follicular Lymphoma
Cell Differentiation
B-Lymphocytes
Interleukin-23
25 Citations (Scopus)

Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease

Mao, F., Tu, Q., Wang, L., Chu, F., Li, X., Li, H. & Xu, W., Jan 1 2017, In : Oncotarget. 8, 23, p. 38008-38021 14 p.

Research output: Contribution to journalReview article

Mesenchymal Stromal Cells
Inflammatory Bowel Diseases
Therapeutics
Cell- and Tissue-Based Therapy
Inflammation
1 Citation (Scopus)

Versatile CAR T-cells for cancer immunotherapy

Chu, F., Cao, J. & Neelalpu, S. S., Jan 1 2017, In : Wspolczesna Onkologia. 2, 1A, p. 73-80 8 p.

Research output: Contribution to journalReview article

Antigen Receptors
Cell- and Tissue-Based Therapy
T-Cell Antigen Receptor
Immunotherapy
T-Cell Antigen Receptor Specificity
10 Citations (Scopus)

Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells

Li, H. S., Liu, C., Xiao, Y., Chu, F., Liang, X., Peng, W., Hu, J., Neelapu, S. S., Sun, S. C., Hwu, P. & Watowich, S. S., Sep 27 2016, In : Science Signaling. 9, 447, ra94.

Research output: Contribution to journalArticle

STAT3 Transcription Factor
Dendritic Cells
Tumors
T-cells
Neoplasms
6 Citations (Scopus)

IL-15 enhances the antitumor effect of human antigen-specific CD8+ T cells by cellular senescence delay

Weng, J., Moriarty, K. E., Baio, F. E., Chu, F., Kim, S. D., He, J., Jie, Z., Xie, X., Ma, W., Qian, J., Zhang, L., Yang, J., Yi, Q., Neelapu, S. S. & Kwak, L. W., Dec 1 2016, In : OncoImmunology. 5, 12, e1237327.

Research output: Contribution to journalArticle

CD8 Antigens
Interleukin-15
Cell Aging
T-Lymphocytes
Interleukin-2